Vicor Technologies, Inc. (VCRT.OB) Announces International Distribution Agreement; Revenues Expected to Commence in the Fourth Quarter of 2009
Vicor Technologies, Inc., a development-stage biotechnology company specializing in innovative, non-invasive diagnostics, recently announced that the company has entered into an exclusive distributorship agreement with Glotecx, Inc. for the distribution of its PD2i Cardiac Analyzer. This agreement grants Glotecx, Inc., a global provider of state-of-the-art medical equipment, the exclusive right to purchase, inventory, promote and resell the private label Vicor PD2i Cardiac Analyzer, and accompanying computer hardware and test analyses in India, Kenya, Uganda, Tanzania and Nigeria. Vicor Technologies’ patented and proprietary PD2i algorithm and software assists patients at risk of sudden cardiac death (SCD) and trauma victims in need…